Litigation Panel
Article | May 25, 2026

Event Recap: A Discussion on Litigation & Government Strategy

Read More
Michelle Schlipp P Illbox
Article | May 21, 2026

Gardner Law Welcomes Michelle Schlipp

Read More
SKI LE Crowd 2
Article | May 21, 2026

Ski-LE 2026 Recap: Key Takeaways for Medical Products Companies

Read More
Opt Out Mechanisms
Article | May 19, 2026

CCPA Enforcement Takes Opt-Out Rights to "Infinity and Beyond"

Read More
Vivian pillbox
Article | May 12, 2026

Gardner Expands Compliance and Litigation Capabilities with Addition of Vivian Egbu

Read More
CMS3
Article | May 05, 2026

CMS Proposes Ending “Fast-Track” NTAP Pathways for Breakthrough Devices

Read More
Mississippi
Article | May 01, 2026

Mississippi Establishes New Medical Device Establishment License and Expands Definition of “Device”

Read More
Bioengineered Standard
Article | April 30, 2026

9th Circuit Tells USDA to Rework Bioengineered Food Disclosure Standard

Read More
Cybersecurity Incident
Article | April 28, 2026

Are You Prepared for a Cybersecurity Incident?

Read More
CMS FDA 01
Article | April 23, 2026

New FDA Programs Full of Promise, but Pitfalls Loom

Read More
3 D Structure of a Peptide
Article | April 21, 2026

The Peptide Boom Meets FDA Reality

Read More
P Illbox GLP 1 Untitled
Article | April 13, 2026

FDA Approves New Oral GLP-1 as Scrutiny of the Market Intensifies

Read More
FTC Logo
Article | April 09, 2026

FTC Turns Up the Heat on Healthcare: Key Implications for Medtech, Pharma, & Biotech Companies

Read More
Pillbox OIG
Article | April 07, 2026

OIG Advisory Opinion 25-11: Key Compliance Insights for Manufacturers

Read More
Jake
Article | April 06, 2026

Gardner Law Expands Compliance Group

Read More
CDS Software
Article | April 02, 2026

CDS Software Final Guidance Carries Real Consequences for Manufacturers

Read More
GLP1 Compounding
Article | March 31, 2026

FDA Escalates Enforcement Against Compounded GLP-1 Marketing

Read More
Texas Privacy Mask
Article | March 26, 2026

Texas AI Law Ups The Ante for Medical AI Use

Read More
OPDP Alert
Article | March 24, 2026

OPDP’s 2026 Untitled Letters: Early Enforcement Trends in Prescription Drug Promotion

Read More
No Artificial Colors2 No Artificial Colors
Article | March 19, 2026

Enforcement Discretion for “No Artificial Colors” Food Labeling Claims

Read More
FDA Image
Article | March 17, 2026

Changing FDA: Can the Agency Keep up with Science?

Read More
3 new states privacy laws
Article | March 12, 2026

No Slowing Down: Three More State Privacy Laws Take Effect

Read More
Handshake Negotating
Article | March 05, 2026

Event Recap: Negotiating Medical Device, Pharmaceutical, and Biotechnology Product Sales Contracts

Read More
Califronia Privacy
Article | March 05, 2026

California Privacy Claims Target Online Tracking

Read More